In Conversation: TJ Parker
Co-Founder, General Medicine (PillPack co-founder) - on building a consumer-facing 'storefront' for healthcare
Some of the clearest thinking in digital health today comes from TJ Parker, Co-Founder, General Medicine (PillPack co-founder). In a wide-ranging conversation conducted by Fierce Healthcare, TJ laid out a view of the industry that is both candid and immediately useful to the executives, clinicians, and builders who read HealthTech Cube.
The conversation
Building a consumer-facing 'storefront' for healthcare - applying PillPack's lessons on price transparency, AI, and ease of access to a much bigger slice of medicine.
“It's a very similar strategy to PillPack.”
- TJ Parker, in conversation with Fierce Healthcare
Conversation highlights
Building a consumer-facing 'storefront' for healthcare
Applying PillPack's lessons on price transparency
And ease of access to a much bigger slice of medicine
The bigger picture
The AI adoption question runs through every executive conversation in 2026. The evidence base is finally arriving: the largest controlled study of ambient documentation, published in JAMA, found clinicians saved 16 minutes of documentation time per day - but only a third of users hit the usage threshold for maximum benefit (our coverage). Meanwhile Rock Health has stopped labeling AI as a differentiator at all, because every company claims it - which is exactly why operating discipline of the kind described here separates winners from demo-ware.
The capital context matters here. US digital health raised $7.4 billion in H1 2026 with 45% of it concentrated in $100M+ megadeals, and 115 acquisitions made it the busiest M&A run since 2021 (our analysis). In a market this concentrated, the strategies described in this conversation - defensible data, measurable outcomes, disciplined growth - are precisely what separates the funded from the folded.
The exchange offers a rare unvarnished look at how these decisions actually get made. At General Medicine (PillPack co-founder), that thinking translates into daily decisions about where technology genuinely earns its place in care delivery, and where discipline matters more than novelty.
The HTC take
As the reimbursement and regulatory ground shifts through 2026 and 2027, this is exactly the kind of leadership thinking worth revisiting.